When Less May Be Enough: Dose Selection Strategies for Immune Checkpoint Inhibitors Focusing on AntiPD-(L)1 Agents.
| Publicado en: | Targeted Oncology Vol. 17; no. 3; pp. 253 - 271 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
May2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=157586555&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 157586555 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17762596 47DQ jtl: Targeted Oncology issn: 17762596 maglogo: N pubinfo: dt: May2022 vid: 17 iid: 3 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 157586555 157351860 10.1007/s11523-022-00890-1 157586555 ppf: 253 ppct: 18 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: When Less May Be Enough: Dose Selection Strategies for Immune Checkpoint Inhibitors Focusing on AntiPD-(L)1 Agents. aug: au: Araujo, Daniel V. Uchoa, Bruno Soto-Castillo, Juan José Furlan, Larissa L. Oliva, Marc affil: Department of Medical Oncology, Hospital de Base/HB Onco, FUNFARME/FAMERP, Av. Brigadeiro Faria Lima 5544, São José do Rio Preto, SP, Brazil sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|